I would think a boutique drug-discovery outfit such as IDIX could do each of these tasks except #1, which requires a comprehensive compound library.
At some point, we ought to see some discussion of what NS5A does for the HCV virus. Was this addressed in the article you read? In any case, I’d be interested in reading the article you read about BMS-790052. T.i.a. for a link, email, or any other reference you may have.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”